128 related articles for article (PubMed ID: 11777638)
1. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
[TBL] [Abstract][Full Text] [Related]
2. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.
Marquez SD; Lum BL; McDougall IR; Katkuri S; Levin PS; MacManus M; Donaldson SS
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):766-74. PubMed ID: 11697323
[TBL] [Abstract][Full Text] [Related]
4. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
[TBL] [Abstract][Full Text] [Related]
5. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
8. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of radiation therapy for Graves' ophthalmopathy.
Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
[TBL] [Abstract][Full Text] [Related]
10. The role of radiation therapy in Graves' ophthalmopathy.
Chowdhury AD; Moriarty MJ
Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
[TBL] [Abstract][Full Text] [Related]
11. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
[TBL] [Abstract][Full Text] [Related]
12. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
13. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
14. Place of radiotherapy in the treatment of Graves' orbitopathy.
Beckendorf V; Maalouf T; George JL; Bey P; Leclere J; Luporsi E
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):805-15. PubMed ID: 10098436
[TBL] [Abstract][Full Text] [Related]
15. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
[No Abstract] [Full Text] [Related]
16. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy.
Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH
Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374
[TBL] [Abstract][Full Text] [Related]
17. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
[TBL] [Abstract][Full Text] [Related]
19. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
20. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
